FIELD: organic chemistry.
SUBSTANCE: invention relates to a compound of general formula [1] or a salt thereof, where R1 is a methyl or ethyl group; R2 represents a hydrogen atom; R3 represents a chlorine atom, methyl, ethyl, isopropyl, butyl, cyclopropylethyl, methylpropyl, hydroxybutyl, trifluoromethyl, cyclopropylvinyl, hydroxybutenyl, cyclopropyl, cyclohexyl, hydroxycyclohexyl, oxocyclohexyl, cyclohexenyl, dimethylamino group or an optionally substituted heterocyclic group, where the heterocyclic group is selected from a group comprising azetidinyl, octahydroisoquinolinyl, morpholinyl, piperidinyl, tetrahydropyranyl and tetrahydropyridinyl, and the substitute is selected from a group comprising methyl, ethyl, hydroxyethyl, methoxyethyl, trifluoroethyl, cyanomethyl, acetyl, methylpropanoyl, tert-butoxycarbonyl, benzoyl, methylsulphonyl, and hydroxy groups; Z1, Z2 and Z3 are CH; X1 is (1) a group represented by the general formula C(=O)N(R6), where carbon atom is bonded with ring A and R6 represents hydrogen atom or methyl; (2) a group represented by the general formula N(R7)C(=O), where the nitrogen atom is bonded to ring A and R7 is methyl; or R7 is, together with one substitute R4 on ring A, an ethylene or propylene group, or a group represented by general formula NH-Y3, where nitrogen atom is connected to ring A, Y3 is an oxo substituted ethylene group; (3) a divalent cyclic hydrocarbon group formed by removal of one hydrogen atom from each of two adjacent atoms in benzene; or (4) optionally substituted with 1–3 substitutes bivalent heterocyclic group formed by removal of one hydrogen atom from each of two adjacent atoms in imidazole, dihydroimidazole, pyrazole, dihydropirazole, triazolidine, triazole, pyrrolidine, pyridine, pyrazolidine or pyrazine, where the substituent group is selected from a group comprising: methyl, ethyl, isopropyl, butyl, hydroxyethyl, methoxyethyl, dimethylaminoethyl, piperidinyl ethyl, morpholinyl ethyl, benzyl and oxo group; ring A is phenyl, naphthyl, thienyl, pyrrolyl, pyridyl, indolyl, indolinyl, isoindolinyl, substituted oxo, quinolyl, isoquinolyl or quinoxalyl; each of m number of groups R4, which are identical or different from each other, is a fluorine atom, a chlorine atom, a cyano group, methyl, ethyl, propyl, isopropyl, tert-butyl, trifluoromethyl, carboxymethyl, hydroxyethyl, methoxyethyl, cyclopropylethyl, cyclopropyl vinyl, hydroxybutenyl, cyclopropyl, cyclohexyl, cyclohexenyl, phenyl, methoxy, ethoxy, trifluoromethoxy, hydroxypropoxy, (dimethylamino) propoxy, ethylamino, butylaminocarbonyl, dimethylamino, methyl (propyl) amino, diethylamino, phenylamino, methylcarbamoyl, dimethylcarbamoyl, isopropylcarbamoyl, (hydroxyethyl) carbamoyl, phenylcarbamoyl, sulphamoyl, methylsulphonyl, methyltetrahydropyridyl, piperidyl, methylpiperidyl, tetrazolyl, amino, acetylamino, (methylsulphonyl) amino, hydroxyethylamino, ((dimethylamino) ethyl) amino group, hydroxyl group, carboxyl group, methoxycarbonyl, tert-butoxycarbonyl group, C3-5 alkylene group formed by two adjacent R4, C2 alkylene groups, taken together taken together by one R4 and R7, or a group represented by general formula NH-Y3, formed by taken together R4 and R7, where nitrogen atom is connected with ring A, Y3 is oxo substituted ethylene group; and m is integer from 0 to 3.
EFFECT: technical result is obtaining novel heterocyclic compounds useful for treating or preventing a disease associated with excessive production of chemokine CXCL10.
14 cl, 29 tbl, 295 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR AGENT AND BROMODOMAIN INHIBITOR | 2017 |
|
RU2752163C2 |
NOVEL AMINE DERIVATIVE OR SALT THEREOF | 2013 |
|
RU2668550C2 |
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2632193C2 |
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR ITS SALT | 2013 |
|
RU2632253C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2005 |
|
RU2556984C2 |
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
Authors
Dates
2020-04-27—Published
2016-07-15—Filed